sémaglutide comprimé Glucoset® Rybelsus for Weight Loss: How

Gordon, O

The effectiveness of GLP-1 agonists for weight loss will depend on the brand or active ingredient

Clinical trial data from the SURMOUNT and SURPASS programs showed tirzepatide patients losing an average of 20 to 25 percent of body weight at the highest doses, compared to roughly 15 to 17 percent for semaglutide in similar trials

The study was led by first author Isabella de Vere Hunt, MD, with co-authors Mariana Ramirez-Posada, Christopher Sam Babu, Cati Brown-Johnson, PhD, Eleni Linos, MD, MPH, DrPH, and Fatima Rodriguez, MD, MPH

Prior investigations have substantiated that an insufficiency of LC results in the enlargement of astrocytes and the expansion of mitochondria in nerve cells [15]